全球 miRNA 市场 2023-2027
市场调查报告书
商品编码
1348435

全球 miRNA 市场 2023-2027

Global miRNA Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 159 Pages | 订单完成后即时交付

价格

miRNA 市场预计在 2022-2027 年期间成长 20,201.2 亿美元,预测期内年复合成长率为 18.91%。

该报告包括对 miRNA 市场的总体分析、市场规模/预测、趋势、成长促进因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和促进因素以及整体市场环境的最新分析。神经系统疾病患病的增加、调查方法的科学进步、调查方法的异质性等正在推动市场。

市场范围
基准年 2022年
结束年份 2027年
系列年 2023-2027
成长动力 加速度
2023 年与前一年同期比较 17.41%
年复合成长率 18.91%
增量 2,020,120,000 美元

研究指出,越来越多的市场供应商联盟和合作是推动未来年度miRNA 市场成长的关键要素之一。此外,新兴经济体的快速成长潜力以及越来越多地采用人工智慧进行疾病评估也可能导致强劲的市场需求。

目录

第1章执行摘要

  • 市场概况

第2章市场形势

  • 市场生态系统

第3章市场规模

  • 市场定义
  • 细分市场分析
  • 2022 年市场规模
  • 2022-2027年市场预测

第4章市场规模实绩

  • 2017-2021年全球miRNA市场
  • 2017-2021 年按类型分類的细分市场分析
  • 2017-2021 年最终用户細項分析
  • 2017-2021 年区域細項分析
  • 2017-2021 年国家細項分析

第5章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代的威胁
  • 竞争威胁
  • 市场状况

第6章市场区隔:按类型

  • 细分市场
  • 比较:按类型
  • 消耗品:2022-2027 年市场规模与预测
  • 仪器:2022-2027 年市场规模与预测
  • 市场机会:按类型

第7章市场区隔:依最终用户

  • 细分市场
  • 比较:按最终用户
  • 学术与政府研究机构:2022-2027 年市场规模与预测
  • 生技与製药公司:2022-2027 年市场规模与预测
  • CRO 与临床诊断中心:2022-2027 年市场规模与预测
  • 市场机会:依最终用户划分

第8章客户形势

  • 客户形势概览

第9章地区形势

  • 区域细分
  • 区域比较
  • 北美:2022-2027 年市场规模与预测
  • 欧洲:2022-2027 年市场规模与预测
  • 亚洲:2022-2027 年市场规模与预测
  • 世界其他地区:2022-2027 年市场规模与预测
  • 美国:2022-2027 年市场规模与预测
  • 德国:2022-2027 年市场规模与预测
  • 英国:2022-2027 年市场规模与预测
  • 加拿大:2022-2027 年市场规模与预测
  • 中国:2022-2027年市场规模及预测
  • 市场机会:按地区

第10章促进因素、挑战与趋势

  • 市场促进因素
  • 市场挑战
  • 促进因素和挑战的影响
  • 市场趋势

第11章供应商形势

  • 概述
  • 供应商形势
  • 混乱的情况
  • 产业风险

第12章供应商分析

  • 交易厂商
  • 供应商市场定位
  • BioVendor Laboratorni medicina AS
  • GeneCopoeia Inc.
  • HEIM BIOTEK
  • Illumina Inc.
  • Merck KGaA
  • Miltenyi Biotec BV and Co. KG
  • NanoString Technologies Inc.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Quantabio
  • Regulus Therapeutics Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第13章附录

Product Code: IRTNTR76209

The MiRNA market is forecasted to grow by USD 2,020.12 mn during 2022-2027, accelerating at a CAGR of 18.91% during the forecast period. The report on the MiRNA market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, significant scientific progress in MiRNA approach, and high heterogeneity of methodologies associated with MiRNA.

Technavio's MiRNA market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 202317.41%
CAGR18.91%
Incremental Value$2020.12mn

By Type

  • Consumables
  • Instruments

By End-user

  • Academic and government research institutes
  • Biotechnology and pharmaceutical companies
  • CROs and clinical diagnostic centers

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing number of partnerships and collaborations of market vendors as one of the prime reasons driving the MiRNA market growth during the next few years. Also, rapid growth potential in developing economies and growing adoption of artificial intelligence for disease evaluation will lead to sizable demand in the market.

The report on the MiRNA market covers the following areas:

  • MiRNA market sizing
  • MiRNA market forecast
  • MiRNA market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading MiRNA market vendors that include BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., Genelinx International Inc., HEIM BIOTEK, Illumina Inc., InteRNA Technologies B.V., Merck KGaA, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAMiRNA GmbH, Thermo Fisher Scientific Inc., and Miltenyi Biotec B.V. and Co. KG. Also, the MiRNA market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global miRNA market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global mirna market 2017 - 2021 ($ million)
  • 4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.3 End-user Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Consumables - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • 6.4 Instruments - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)
  • Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
  • 7.2 Comparison by End-user
  • Exhibit 46: Chart on Comparison by End-user
  • Exhibit 47: Data Table on Comparison by End-user
  • 7.3 Academic and government research institutes - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Academic and government research institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Academic and government research institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Academic and government research institutes - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Academic and government research institutes - Year-over-year growth 2022-2027 (%)
  • 7.4 Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • 7.5 CROs and clinical diagnostic centers - Market size and forecast 2022-2027
  • Exhibit 56: Chart on CROs and clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on CROs and clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on CROs and clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on CROs and clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by End-user
  • Exhibit 60: Market opportunity by End-user ($ million)
  • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
  • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 103: Market opportunity by geography ($ million)
  • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 BioVendor Laboratorni medicina AS
  • Exhibit 111: BioVendor Laboratorni medicina AS - Overview
  • Exhibit 112: BioVendor Laboratorni medicina AS - Product / Service
  • Exhibit 113: BioVendor Laboratorni medicina AS - Key offerings
  • 12.4 GeneCopoeia Inc.
  • Exhibit 114: GeneCopoeia Inc. - Overview
  • Exhibit 115: GeneCopoeia Inc. - Product / Service
  • Exhibit 116: GeneCopoeia Inc. - Key offerings
  • 12.5 HEIM BIOTEK
  • Exhibit 117: HEIM BIOTEK - Overview
  • Exhibit 118: HEIM BIOTEK - Product / Service
  • Exhibit 119: HEIM BIOTEK - Key offerings
  • 12.6 Illumina Inc.
  • Exhibit 120: Illumina Inc. - Overview
  • Exhibit 121: Illumina Inc. - Business segments
  • Exhibit 122: Illumina Inc. - Key news
  • Exhibit 123: Illumina Inc. - Key offerings
  • Exhibit 124: Illumina Inc. - Segment focus
  • 12.7 Merck KGaA
  • Exhibit 125: Merck KGaA - Overview
  • Exhibit 126: Merck KGaA - Business segments
  • Exhibit 127: Merck KGaA - Key news
  • Exhibit 128: Merck KGaA - Key offerings
  • Exhibit 129: Merck KGaA - Segment focus
  • 12.8 Miltenyi Biotec B.V. and Co. KG
  • Exhibit 130: Miltenyi Biotec B.V. and Co. KG - Overview
  • Exhibit 131: Miltenyi Biotec B.V. and Co. KG - Product / Service
  • Exhibit 132: Miltenyi Biotec B.V. and Co. KG - Key offerings
  • 12.9 NanoString Technologies Inc.
  • Exhibit 133: NanoString Technologies Inc. - Overview
  • Exhibit 134: NanoString Technologies Inc. - Product / Service
  • Exhibit 135: NanoString Technologies Inc. - Key offerings
  • 12.10 New England Biolabs Inc.
  • Exhibit 136: New England Biolabs Inc. - Overview
  • Exhibit 137: New England Biolabs Inc. - Product / Service
  • Exhibit 138: New England Biolabs Inc. - Key offerings
  • 12.11 OriGene Technologies Inc.
  • Exhibit 139: OriGene Technologies Inc. - Overview
  • Exhibit 140: OriGene Technologies Inc. - Product / Service
  • Exhibit 141: OriGene Technologies Inc. - Key offerings
  • 12.12 PerkinElmer Inc.
  • Exhibit 142: PerkinElmer Inc. - Overview
  • Exhibit 143: PerkinElmer Inc. - Business segments
  • Exhibit 144: PerkinElmer Inc. - Key news
  • Exhibit 145: PerkinElmer Inc. - Key offerings
  • Exhibit 146: PerkinElmer Inc. - Segment focus
  • 12.13 QIAGEN NV
  • Exhibit 147: QIAGEN NV - Overview
  • Exhibit 148: QIAGEN NV - Product / Service
  • Exhibit 149: QIAGEN NV - Key news
  • Exhibit 150: QIAGEN NV - Key offerings
  • 12.14 Quantabio
  • Exhibit 151: Quantabio - Overview
  • Exhibit 152: Quantabio - Product / Service
  • Exhibit 153: Quantabio - Key offerings
  • 12.15 Regulus Therapeutics Inc.
  • Exhibit 154: Regulus Therapeutics Inc. - Overview
  • Exhibit 155: Regulus Therapeutics Inc. - Product / Service
  • Exhibit 156: Regulus Therapeutics Inc. - Key offerings
  • 12.16 Takara Bio Inc.
  • Exhibit 157: Takara Bio Inc. - Overview
  • Exhibit 158: Takara Bio Inc. - Product / Service
  • Exhibit 159: Takara Bio Inc. - Key offerings
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 160: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 161: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 162: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 163: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 164: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 165: Inclusions checklist
  • Exhibit 166: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 167: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 168: Research methodology
  • Exhibit 169: Validation techniques employed for market sizing
  • Exhibit 170: Information sources
  • 13.5 List of abbreviations
  • Exhibit 171: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global mirna market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Type ($ million)
  • Exhibits43: Data Table on Market opportunity by Type ($ million)
  • Exhibits44: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by End-user
  • Exhibits47: Data Table on Comparison by End-user
  • Exhibits48: Chart on Academic and government research institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on Academic and government research institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on Academic and government research institutes - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Academic and government research institutes - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Chart on CROs and clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on CROs and clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on CROs and clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on CROs and clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Market opportunity by End-user ($ million)
  • Exhibits61: Data Table on Market opportunity by End-user ($ million)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share by geography 2022-2027 (%)
  • Exhibits64: Data Table on Market share by geography 2022-2027 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Market opportunity by geography ($ million)
  • Exhibits104: Data Tables on Market opportunity by geography ($ million)
  • Exhibits105: Impact of drivers and challenges in 2022 and 2027
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: BioVendor Laboratorni medicina AS - Overview
  • Exhibits112: BioVendor Laboratorni medicina AS - Product / Service
  • Exhibits113: BioVendor Laboratorni medicina AS - Key offerings
  • Exhibits114: GeneCopoeia Inc. - Overview
  • Exhibits115: GeneCopoeia Inc. - Product / Service
  • Exhibits116: GeneCopoeia Inc. - Key offerings
  • Exhibits117: HEIM BIOTEK - Overview
  • Exhibits118: HEIM BIOTEK - Product / Service
  • Exhibits119: HEIM BIOTEK - Key offerings
  • Exhibits120: Illumina Inc. - Overview
  • Exhibits121: Illumina Inc. - Business segments
  • Exhibits122: Illumina Inc. - Key news
  • Exhibits123: Illumina Inc. - Key offerings
  • Exhibits124: Illumina Inc. - Segment focus
  • Exhibits125: Merck KGaA - Overview
  • Exhibits126: Merck KGaA - Business segments
  • Exhibits127: Merck KGaA - Key news
  • Exhibits128: Merck KGaA - Key offerings
  • Exhibits129: Merck KGaA - Segment focus
  • Exhibits130: Miltenyi Biotec B.V. and Co. KG - Overview
  • Exhibits131: Miltenyi Biotec B.V. and Co. KG - Product / Service
  • Exhibits132: Miltenyi Biotec B.V. and Co. KG - Key offerings
  • Exhibits133: NanoString Technologies Inc. - Overview
  • Exhibits134: NanoString Technologies Inc. - Product / Service
  • Exhibits135: NanoString Technologies Inc. - Key offerings
  • Exhibits136: New England Biolabs Inc. - Overview
  • Exhibits137: New England Biolabs Inc. - Product / Service
  • Exhibits138: New England Biolabs Inc. - Key offerings
  • Exhibits139: OriGene Technologies Inc. - Overview
  • Exhibits140: OriGene Technologies Inc. - Product / Service
  • Exhibits141: OriGene Technologies Inc. - Key offerings
  • Exhibits142: PerkinElmer Inc. - Overview
  • Exhibits143: PerkinElmer Inc. - Business segments
  • Exhibits144: PerkinElmer Inc. - Key news
  • Exhibits145: PerkinElmer Inc. - Key offerings
  • Exhibits146: PerkinElmer Inc. - Segment focus
  • Exhibits147: QIAGEN NV - Overview
  • Exhibits148: QIAGEN NV - Product / Service
  • Exhibits149: QIAGEN NV - Key news
  • Exhibits150: QIAGEN NV - Key offerings
  • Exhibits151: Quantabio - Overview
  • Exhibits152: Quantabio - Product / Service
  • Exhibits153: Quantabio - Key offerings
  • Exhibits154: Regulus Therapeutics Inc. - Overview
  • Exhibits155: Regulus Therapeutics Inc. - Product / Service
  • Exhibits156: Regulus Therapeutics Inc. - Key offerings
  • Exhibits157: Takara Bio Inc. - Overview
  • Exhibits158: Takara Bio Inc. - Product / Service
  • Exhibits159: Takara Bio Inc. - Key offerings
  • Exhibits160: Thermo Fisher Scientific Inc. - Overview
  • Exhibits161: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits162: Thermo Fisher Scientific Inc. - Key news
  • Exhibits163: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits164: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits165: Inclusions checklist
  • Exhibits166: Exclusions checklist
  • Exhibits167: Currency conversion rates for US$
  • Exhibits168: Research methodology
  • Exhibits169: Validation techniques employed for market sizing
  • Exhibits170: Information sources
  • Exhibits171: List of abbreviations